Last reviewed · How we verify

PCEC rabies vaccine administered intramuscularly

Centers for Disease Control and Prevention · Phase 1 active Biologic

PCEC rabies vaccine administered intramuscularly is a Biologic drug developed by Centers for Disease Control and Prevention. It is currently in Phase 1 development. Also known as: RabAvert.

At a glance

Generic namePCEC rabies vaccine administered intramuscularly
Also known asRabAvert
SponsorCenters for Disease Control and Prevention
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PCEC rabies vaccine administered intramuscularly

What is PCEC rabies vaccine administered intramuscularly?

PCEC rabies vaccine administered intramuscularly is a Biologic drug developed by Centers for Disease Control and Prevention.

Who makes PCEC rabies vaccine administered intramuscularly?

PCEC rabies vaccine administered intramuscularly is developed by Centers for Disease Control and Prevention (see full Centers for Disease Control and Prevention pipeline at /company/centers-for-disease-control-and-prevention).

Is PCEC rabies vaccine administered intramuscularly also known as anything else?

PCEC rabies vaccine administered intramuscularly is also known as RabAvert.

What development phase is PCEC rabies vaccine administered intramuscularly in?

PCEC rabies vaccine administered intramuscularly is in Phase 1.

Related